Leap Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LPTX and buy or sell other stocks, ETFs, and their options commission-free!About LPTX
Cypherpunk Technologies, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer.
CEODoug E. Onsi
CEODoug E. Onsi
Employees52
Employees52
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees52
Employees52
LPTX Key Statistics
Market cap144.00M
Market cap144.00M
Price-Earnings ratio-0.85
Price-Earnings ratio-0.85
Dividend yield—
Dividend yield—
Average volume3.76M
Average volume3.76M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.70
52 Week high$3.70
52 Week low$0.2223
52 Week low$0.2223
Stock Snapshot
Leap Therapeutics(LPTX) stock is priced at $3.48, giving the company a market capitalization of 144M. It carries a P/E multiple of -0.85.
On 2026-01-14, Leap Therapeutics(LPTX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Leap Therapeutics(LPTX) stock has reached 0, versus its average volume of 3.76M.
Over the past 52 weeks, Leap Therapeutics(LPTX) stock has traded between a high of $3.70 and a low of $0.22.
Over the past 52 weeks, Leap Therapeutics(LPTX) stock has traded between a high of $3.70 and a low of $0.22.
People also own
Based on the portfolios of people who own LPTX. This list is generated using Robinhood data, and it’s not a recommendation.